SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-23-027355
Filing Date
2023-08-09
Accepted
2023-08-09 16:15:20
Documents
2

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 89245
2 ex1.htm EX-1 4231
  Complete submission text file 0001493152-23-027355.txt   95174
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Subject) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-86249 | Film No.: 231155348
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 MADISON AVENUE 35TH FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 35TH FLOOR NEW YORK NY 10022 917-970-1730
COMMODORE CAPITAL LP (Filed by) CIK: 0001831942 (see all company filings)

IRS No.: 832659606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G